Edwards Lifesciences Corporation Logo

Edwards Lifesciences Corporation (1EW)

MTA

Currency in EUR
75.80
0.00 (0.00%)

Real-time Data

07:00 AM

Day's Range

75.80
75.80

52 wk Range

63.84
82.24

Overview - 1EW - Edwards Lifesciences Corporation

Key Statistics

Valuation

Enterprise Value

35.54B

P/E (Trailing)

‪51.52‬

PEG Ratio

‪-1.95‬

Price / Sales (TTM)

‪6.74‬

Price / Book

‪4.74‬

EV / EBITDA

‪20.29‬

Profitability

Gross Margin

‪77.46%‬

Profit Margin

‪15.43%‬

Operating Margin

‪29.83%‬

Return on Assets

‪8.36%‬

Return on Equity

‪9.17%‬

Ownership

Shares Outstanding

576.60M

Float

574.49M

Held by Insiders

‪0.19%‬

Held by Institutions

‪95.72%‬

Price stats

Beta

‪0.85‬

50-Day Avg

‪77.07‬

200-Day Avg

‪73.32‬

Dividends

Payout Ratio

‪0.00%‬

News Teaser - 1EW - Edwards Lifesciences Corporation

News & Analysis

View all news

Market Cap - 1EW - Edwards Lifesciences Corporation

Peers - 1EW - Edwards Lifesciences Corporation

Peer Comparison

Compared with companies in Medical Devices listed on MTA.

Profile Summary - 1EW - Edwards Lifesciences Corporation

About

Edwards Lifesciences Corporation is a medical technology company focused on structural heart disease and critical care monitoring. Edwards Lifesciences develops and markets transcatheter aortic valve replacement systems, transcatheter mitral and tricuspid therapies, and surgical structural heart products used to…

SectorHealthcare
IndustryMedical Devices
Employees16K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.